These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3974347)

  • 1. [Serum levels and spirometric response with sustained release theophylline].
    Otero MJ; Barrueco M; Mariño EL; Gómez F; de Portugal J; Domínguez-Gil A
    Med Clin (Barc); 1985 Jan; 84(2):51-3. PubMed ID: 3974347
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic asthma in children: comparison between a delayed-action theophylline preparation and a prompt-release aminophylline preparation].
    Longo G; Poli F; Strinati R; Longo F
    Pediatr Med Chir; 1984; 6(5):645-9. PubMed ID: 6535126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of circadian variation in serum theophylline levels in the sustained-release theophylline treatment of chronic asthma].
    Watanabe A; Urata C; Nomoto H; Mizobe M; Abe Y; Mano K; Miyamato Y; Sano Y
    Arerugi; 1986 Jul; 35(7):447-54. PubMed ID: 3778214
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of Euphylline-retard based on the measurement of theophylline concentration in the blood serum and spirometric parameters].
    Pietruszewska E; Droszcz W; Wrońska J; Kowalski J
    Pneumonol Pol; 1981 Nov; 49(11):783-9. PubMed ID: 7342049
    [No Abstract]   [Full Text] [Related]  

  • 5. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the plasma profiles of two slow release theophylline preparations in asthmatic patients and healthy volunteers.
    Langaker KE; Bredesen JE; Holland A
    Br J Clin Pract Suppl; 1984; 35():50-2. PubMed ID: 6433960
    [No Abstract]   [Full Text] [Related]  

  • 7. [Aminophylline-retard preparation in the treatment of patients with bronchial asthma].
    Branica S; Vrabec B; Francetić I; Bakran I
    Lijec Vjesn; 1989; 111(9-10):341-3. PubMed ID: 2633012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A dose-concentration relationship study in different dosage regimens for theophylline preparations: intravenous for euphylline and peroral for prolonged-action forms].
    Tsoĭ AN; Bogovskiĭ BP; Gavrilenko LN; Kushkenbaeva BE; Kukes VG
    Ter Arkh; 1990; 62(9):22-5. PubMed ID: 2281401
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum theophylline levels in adult asthmatics: comparison of oral sustained-release and microcrystalline preparations.
    Jones DT; Sears MR
    N Z Med J; 1980 Sep; 92(667):196-8. PubMed ID: 6933358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW; Zech K; Fischer R
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theophylline administration in children with asthma: optimal pulmonary function and possible tolerance to chronic administration.
    Katz RM; Rachelefsky GS; Siegel SC; Mickey R
    Ann Allergy; 1983 Jan; 50(1):23-6. PubMed ID: 6849515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between pharmacodynamics and pharmacokinetics in asthmatic children receiving a sustained-release formulation of theophylline.
    Schaefers M; Richter O; Reinhardt D; Becker B
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):406-15. PubMed ID: 6490223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
    Wiesner B; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
    Beer S; Laver J; Benson L; Cotariu D; Neli P; Saidman JL; Viure E
    Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-effect relationship of a controlled release theophylline preparation in pre-school children.
    Duiverman EJ; Neijens HJ; Kerrebijn KF
    Br J Clin Pract Suppl; 1984; 35():55-6. PubMed ID: 6433962
    [No Abstract]   [Full Text] [Related]  

  • 16. [Usefulness of "Biotrack Theophylline kit" for measuring serum theophylline concentration in patients with chronic asthma].
    Iwata T
    Nihon Rinsho; 1996 Nov; 54(11):3113-8. PubMed ID: 8950964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 21-day double-blind study of the effect of adding sustained-release theophylline (Nuelin SA) to inhaled salbutamol in patients with asthma.
    Sahay JN; Chatterjee SS
    Br J Dis Chest; 1983 Jan; 77(1):66-70. PubMed ID: 6344899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
    Schulz HU; Steinijans VW; Gabel H
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
    van der Vet AP; Drost RH; Kreukniet J; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The anti-inflammatory action of an oral sustained-release theophylline preparation. Results of a clinical pilot study with low dosages].
    Bodner A; Hens C; Moser C; Oster H
    Arzneimittelforschung; 1998 May; 48(5A):617-24. PubMed ID: 9676355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.